BENDAMUSTINE AND PREDNISONE IN COMBINATION WITH BORTEZOMIB (BPV) IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED/UNTREATED MULTIPLE MYELOMA

被引:0
|
作者
Poenisch, W. [1 ]
Holzvogt, B. [1 ]
Ploetze, M. [1 ]
Andrea, M. [1 ]
Lange, T. [1 ]
Niederwieser, D. [1 ]
机构
[1] Univ Leipzig, D-04109 Leipzig, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P961
引用
收藏
页码:362 / 363
页数:2
相关论文
共 50 条
  • [21] Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma
    Wolfram Poenisch
    Madlen Plötze
    Bruno Holzvogt
    Marc Andrea
    Thomas Schliwa
    Thomas Zehrfeld
    Doreen Hammerschmidt
    Maik Schwarz
    Thomas Edelmann
    Cornelia Becker
    Franz Albert Hoffmann
    Andreas Schwarzer
    Ute Kreibich
    Kerstin Gutsche
    Kolja Reifenrath
    Heidrun Schwarzbach
    Simone Heyn
    Georg-Nikolaus Franke
    Madlen Jentzsch
    Sabine Leiblein
    Sebastian Schwind
    Thoralf Lange
    Vladan Vucinic
    Haifa-Katrin AlAli
    Dietger Niederwieser
    [J]. Journal of Cancer Research and Clinical Oncology, 2015, 141 : 2013 - 2022
  • [22] Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma
    Poenisch, Wolfram
    Ploetze, Madlen
    Holzvogt, Bruno
    Andrea, Marc
    Schliwa, Thomas
    Zehrfeld, Thomas
    Hammerschmidt, Doreen
    Schwarz, Maik
    Edelmann, Thomas
    Becker, Cornelia
    Hoffmann, Franz Albert
    Schwarzer, Andreas
    Kreibich, Ute
    Gutsche, Kerstin
    Reifenrath, Kolja
    Schwarzbach, Heidrun
    Heyn, Simone
    Franke, Georg-Nikolaus
    Jentzsch, Madlen
    Leiblein, Sabine
    Schwind, Sebastian
    Lange, Thoralf
    Vucinic, Vladan
    Alali, Haifa-Katrin
    Niederwieser, Dietger
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (11) : 2013 - 2022
  • [23] Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure
    Wolfram Pönisch
    Barbara Moll
    Malvina Bourgeois
    Marc Andrea
    Thomas Schliwa
    Simone Heyn
    Marion Schmalfeld
    Thomas Edelmann
    Cornelia Becker
    Franz Albert Hoffmann
    Andreas Schwarzer
    Ute Kreibich
    Matthias Egert
    Runa Stiegler
    Rainer Krahl
    Yvonne Remane
    Anette Bachmann
    Tom Lindner
    Lorenz Weidhase
    Sirak Petros
    Stefan Fricke
    Vladan Vucinic
    Haifa Al Ali
    Dietger Niederwieser
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1937 - 1946
  • [24] Bendamustine, prednisone, and bortezomib (BPV) as induction followed by high-dose therapy and ASCT in newly diagnosed multiple myeloma patients with impaired renal function
    Wang, S. Y.
    Fricke, S.
    Vucinic, V.
    Franke, G. N.
    Heyn, S.
    Hell, S.
    Schetschorke, B.
    Jentzsch, M.
    Schwind, S.
    Zehrfeld, T.
    Braunert, L.
    Edelmann, T.
    Becker, C.
    Hoffmann, F. A.
    Reifenrath, K.
    Schwarz, M.
    Schwarzer, A.
    Hammerschmidt, D.
    Platzbecker, U.
    Merz, M.
    Poenisch, W.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 141 - 141
  • [25] Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure
    Poenisch, Wolfram
    Moll, Barbara
    Bourgeois, Malvina
    Andrea, Marc
    Schliwa, Thomas
    Heyn, Simone
    Schmalfeld, Marion
    Edelmann, Thomas
    Becker, Cornelia
    Hoffmann, Franz Albert
    Schwarzer, Andreas
    Kreibich, Ute
    Egert, Matthias
    Stiegler, Runa
    Krahl, Rainer
    Remane, Yvonne
    Bachmann, Anette
    Lindner, Tom
    Weidhase, Lorenz
    Petros, Sirak
    Fricke, Stefan
    Vucinic, Vladan
    Al Ali, Haifa
    Niederwieser, Dietger
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (11) : 1937 - 1946
  • [26] Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial
    Mateos, Maria-Victoria
    Oriol, Albert
    Rosinol, Laura
    de Arriba, Felipe
    Puig, Noemi
    Martin, Jesus
    Martinez-Lopez, Joaquin
    Asuncion Echeveste, Maria
    Sarra, Josep
    Ocio, Enrique
    Ramirez, Gemma
    Martinez, Rafael
    Palomera, Luis
    Payer, Angel
    Iglesias, Rebeca
    de la Rubia, Javier
    Alegre, Adrian
    Isabel Chinea, Ana
    Blade, Joan
    Jose Lahuerta, Juan
    San Miguel, Jesus-F.
    [J]. HAEMATOLOGICA, 2015, 100 (08) : 1096 - 1102
  • [27] STEM CELL MOBILIZATION AND AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER INDUCTION WITH BENDAMUSTINE, PREDNISONE AND BORTEZOMIB (BPV) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH RENAL IMPAIRMENT
    Fricke, Susann
    Poenisch, Wolfram
    Holzhey, Tanja
    Holzvogt, Madlen
    Andrea, Marc
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Heyn, Simone
    Hell, Saskia
    Schetschorke, Birthe
    Jentzsch, Madlen
    Schwind, Sebastian
    Zehrfeld, Thomas
    Braunert, Leanthe
    Edelmann, Thomas
    Becker, Cornelia
    Hoffmann, Franz-Albert
    Reifenrath, Kolja
    Schwarz, Maik
    Schwarzer, Andreas
    Flade, Franziska
    Hammerschmidt, Dorren
    Scholz, Markus
    Platzbecker, Uwe
    Merz, Maximilian
    Wang, Song-Yau
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 490 - 490
  • [28] Phase 2 Study Of Bendamustine, Bortezomib (Velcade) and Prednisone (BVP) For Newly Diagnosed Multiple Myeloma (MM)
    Mateos, Maria-Victoria
    Oriol, Albert
    Rosinol, Laura
    de Arriba, Felipe
    Martin, Jesus
    Martinez-Lopez, Joaquin
    Asuncion Echeveste, Maria
    Sarra, Josep
    Ramirez, Gemma
    Ocio, Enrique M.
    Martinez, Rafael
    Palomera, Luis
    Payer, Angel
    Iglesias, Rebeca
    De La Rubia, Javier
    Alegre, Adrian
    Chinea, Anabelle
    Blade, Joan
    Jose Lahuerta, Juan
    San Miguel, Jesus F.
    [J]. BLOOD, 2013, 122 (21)
  • [29] Subcutaneous Bortezomib, Melphalan and Prednisone in Elderly Newly Diagnosed Multiple Myeloma Patients
    Herbaux, Charles
    Joao, Cristina M.
    Plocque, Alexia
    Richez, Valentine
    Gay, Francesca
    Renaud, Loic
    Legros, Laurence
    Garderet, Laurent
    Ikhlef, Souhila
    Pegourie, Brigitte
    Escoffre-Barbe, Martine
    Royer, Bruno
    Voillat, Laurent
    Hulin, Cyrille
    Banos, Anne
    Voog, Eric G.
    Karlin, Lionel
    Stoppa, Anne-Marie
    Benboubker, Lotfi
    Zweegman, Sonja
    De Jongh, Eva
    Abildgaard, Niels
    Le Du, Katell
    Jurczyszyn, Artur J.
    Moreau, Philippe
    Facon, Thierry
    Caillot, Denis
    Terpos, Evangelos
    Leleu, Xavier
    [J]. BLOOD, 2014, 124 (21)
  • [30] Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients
    He, Jingsong
    Yang, Li
    Jin, Dian
    Lin, Xuanru
    Yang, Qianqian
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Zhang, Jie
    Lin, Maofang
    Huang, He
    Cai, Zhen
    [J]. BLOOD, 2012, 120 (21)